HYDROXYUREA for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 31 adverse event reports in the FDA FAERS database where HYDROXYUREA was used for Psoriasis.
Most Reported Side Effects for HYDROXYUREA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 519 | 8.7% | 63 | 189 |
| Anaemia | 358 | 6.0% | 50 | 188 |
| Drug ineffective | 356 | 6.0% | 81 | 103 |
| Fatigue | 291 | 4.9% | 11 | 94 |
| Thrombocytopenia | 253 | 4.2% | 38 | 149 |
| Nausea | 247 | 4.1% | 8 | 95 |
| Pyrexia | 243 | 4.1% | 37 | 161 |
| Diarrhoea | 222 | 3.7% | 19 | 101 |
| Febrile neutropenia | 202 | 3.4% | 25 | 107 |
| Intentional product use issue | 201 | 3.4% | 11 | 49 |
| Dyspnoea | 184 | 3.1% | 14 | 87 |
| Platelet count decreased | 175 | 2.9% | 27 | 70 |
| Platelet count increased | 174 | 2.9% | 3 | 44 |
| Headache | 173 | 2.9% | 5 | 68 |
| Skin ulcer | 173 | 2.9% | 7 | 60 |
Other Indications for HYDROXYUREA
Product used for unknown indication (1,619)
Essential thrombocythaemia (629)
Polycythaemia vera (552)
Chronic myeloid leukaemia (457)
Sickle cell disease (246)
Acute myeloid leukaemia (230)
Thrombocytosis (184)
Myeloproliferative neoplasm (162)
Myelofibrosis (129)
Sickle cell anaemia (119)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)